Punch & Associates Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,707
Closed -$567K 216
2023
Q4
$567K Sell
19,707
-460
-2% -$13.9K 0.03% 173
2023
Q3
$669K Buy
20,167
+2,739
+16% +$96.9K 0.04% 168
2023
Q2
$639K Buy
17,428
+1,807
+12% +$70.3K 0.04% 173
2023
Q1
$637K Sell
15,621
-4,000
-20% -$173K 0.04% 166
2022
Q4
$1.01M Hold
19,621
0.07% 163
2022
Q3
$859K Hold
19,621
0.06% 164
2022
Q2
$1.03M Sell
19,621
-922
-4% -$47K 0.07% 167
2022
Q1
$1.06M Buy
20,543
+926
+5% +$48K 0.06% 168
2021
Q4
$1.16M Hold
19,617
0.06% 175
2021
Q3
$844K Hold
19,617
0.05% 183
2021
Q2
$768K Hold
19,617
0.04% 187
2021
Q1
$711K Hold
19,617
0.04% 189
2020
Q4
$722K Sell
19,617
-1,778
-8% -$65.2K 0.05% 181
2020
Q3
$745K Hold
21,395
0.06% 178
2020
Q2
$664K Hold
21,395
0.06% 179
2020
Q1
$663K Buy
21,395
+4,216
+25% +$144K 0.08% 168
2019
Q4
$639K Hold
17,179
0.05% 174
2019
Q3
$586K Sell
17,179
-422
-2% -$15.3K 0.05% 176
2019
Q2
$723K Sell
17,601
-150
-0.8% -$5.96K 0.06% 173
2019
Q1
$715K Hold
17,751
0.06% 172
2018
Q4
$735K Buy
17,751
+150
+0.9% +$6.23K 0.07% 181
2018
Q3
$736K Hold
17,601
0.06% 179
2018
Q2
$606K Buy
+17,601
New +$601K 0.05% 178

Other funds holding PFE

Punch & Associates Investment Management's PFE Position: Q1 2024 in Review

Punch & Associates Investment Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 19,707 shares — an estimated $567K sold.

Punch & Associates Investment Management first reported a position in PFE in Q2 2018 and held it in 23 quarters. The position peaked at $1.16M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Punch & Associates Investment Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Punch & Associates Investment Management sold 19,707 Pfizer shares in Q1 2024, an estimated $567K.
  • Punch & Associates Investment Management first reported a position in Pfizer in Q2 2018 and held it in 23 quarters.
  • Punch & Associates Investment Management's Pfizer position peaked at $1.16M in Q4 2021.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Punch & Associates Investment Management's 13F filing for Q1 2024, filed 15 May 2024.